These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 18372227

  • 1. Mechanisms of glucocorticoid-induced myopathy.
    Schakman O, Gilson H, Thissen JP.
    J Endocrinol; 2008 Apr; 197(1):1-10. PubMed ID: 18372227
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid-induced skeletal muscle atrophy.
    Schakman O, Kalista S, Barbé C, Loumaye A, Thissen JP.
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of muscle atrophy induced by glucocorticoids.
    Schakman O, Gilson H, Kalista S, Thissen JP.
    Horm Res; 2009 Nov; 72 Suppl 1():36-41. PubMed ID: 19940494
    [Abstract] [Full Text] [Related]

  • 4. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
    Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C, Lee RT, Rosenthal N.
    Circ Res; 2005 Sep 02; 97(5):418-26. PubMed ID: 16051886
    [Abstract] [Full Text] [Related]

  • 5. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
    Gilson H, Schakman O, Combaret L, Lause P, Grobet L, Attaix D, Ketelslegers JM, Thissen JP.
    Endocrinology; 2007 Jan 02; 148(1):452-60. PubMed ID: 17038559
    [Abstract] [Full Text] [Related]

  • 6. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ.
    Curr Top Microbiol Immunol; 2010 Jan 02; 346():267-78. PubMed ID: 20593312
    [Abstract] [Full Text] [Related]

  • 7. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
    Dehoux M, Gobier C, Lause P, Bertrand L, Ketelslegers JM, Thissen JP.
    Am J Physiol Endocrinol Metab; 2007 Jan 02; 292(1):E145-50. PubMed ID: 16926385
    [Abstract] [Full Text] [Related]

  • 8. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B, Cartoni R, Praz M, Lamon S, Dériaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F, Russell AP.
    J Physiol; 2006 Nov 01; 576(Pt 3):923-33. PubMed ID: 16916907
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
    Umeki D, Ohnuki Y, Mototani Y, Shiozawa K, Suita K, Fujita T, Nakamura Y, Saeki Y, Okumura S.
    PLoS One; 2015 Nov 01; 10(6):e0128263. PubMed ID: 26053620
    [Abstract] [Full Text] [Related]

  • 11. FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy.
    Zheng B, Ohkawa S, Li H, Roberts-Wilson TK, Price SR.
    FASEB J; 2010 Aug 01; 24(8):2660-9. PubMed ID: 20371624
    [Abstract] [Full Text] [Related]

  • 12. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy.
    Hulmi JJ, Silvennoinen M, Lehti M, Kivelä R, Kainulainen H.
    Am J Physiol Endocrinol Metab; 2012 Feb 01; 302(3):E307-15. PubMed ID: 22068602
    [Abstract] [Full Text] [Related]

  • 13. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
    Doucet M, Russell AP, Léger B, Debigaré R, Joanisse DR, Caron MA, LeBlanc P, Maltais F.
    Am J Respir Crit Care Med; 2007 Aug 01; 176(3):261-9. PubMed ID: 17478621
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage.
    Wang R, Jiao H, Zhao J, Wang X, Lin H.
    PLoS One; 2016 Aug 01; 11(5):e0156225. PubMed ID: 27227776
    [Abstract] [Full Text] [Related]

  • 15. Skeletal muscle hypertrophy and atrophy signaling pathways.
    Glass DJ.
    Int J Biochem Cell Biol; 2005 Oct 01; 37(10):1974-84. PubMed ID: 16087388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling.
    Pansters NA, Langen RC, Wouters EF, Schols AM.
    J Appl Physiol (1985); 2013 May 01; 114(9):1329-39. PubMed ID: 22936724
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats.
    Schakman O, Gilson H, de Coninck V, Lause P, Verniers J, Havaux X, Ketelslegers JM, Thissen JP.
    Endocrinology; 2005 Apr 01; 146(4):1789-97. PubMed ID: 15661854
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats.
    Nishida H, Ikegami A, Kaneko C, Kakuma H, Nishi H, Tanaka N, Aoyama M, Usami M, Okimura Y.
    PLoS One; 2015 Apr 01; 10(6):e0128805. PubMed ID: 26086773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.